Literature DB >> 15902263

Structure of the zinc-binding domain of an essential component of the hepatitis C virus replicase.

Timothy L Tellinghuisen1, Joseph Marcotrigiano, Charles M Rice.   

Abstract

Hepatitis C virus (HCV) is a human pathogen affecting nearly 3% of the world's population. Chronic infections can lead to cirrhosis and liver cancer. The RNA replication machine of HCV is a multi-subunit membrane-associated complex. The non-structural protein NS5A is an active component of HCV replicase, as well as a pivotal regulator of replication and a modulator of cellular processes ranging from innate immunity to dysregulated cell growth. NS5A is a large phosphoprotein (56-58 kDa) with an amphipathic alpha-helix at its amino terminus that promotes membrane association. After this helix region, NS5A is organized into three domains. The N-terminal domain (domain I) coordinates a single zinc atom per protein molecule. Mutations disrupting either the membrane anchor or zinc binding of NS5A are lethal for RNA replication. However, probing the role of NS5A in replication has been hampered by a lack of structural information about this multifunctional protein. Here we report the structure of NS5A domain I at 2.5-A resolution, which contains a novel fold, a new zinc-coordination motif and a disulphide bond. We use molecular surface analysis to suggest the location of protein-, RNA- and membrane-interaction sites.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15902263      PMCID: PMC1440517          DOI: 10.1038/nature03580

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  24 in total

1.  Electrostatics of nanosystems: application to microtubules and the ribosome.

Authors:  N A Baker; D Sept; S Joseph; M J Holst; J A McCammon
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-21       Impact factor: 11.205

Review 2.  Mapping the protein universe.

Authors:  L Holm; C Sander
Journal:  Science       Date:  1996-08-02       Impact factor: 47.728

Review 3.  Principles of protein-protein interactions.

Authors:  S Jones; J M Thornton
Journal:  Proc Natl Acad Sci U S A       Date:  1996-01-09       Impact factor: 11.205

4.  Dictionary of protein secondary structure: pattern recognition of hydrogen-bonded and geometrical features.

Authors:  W Kabsch; C Sander
Journal:  Biopolymers       Date:  1983-12       Impact factor: 2.505

5.  Analysis of zinc binding sites in protein crystal structures.

Authors:  I L Alberts; K Nadassy; S J Wodak
Journal:  Protein Sci       Date:  1998-08       Impact factor: 6.725

6.  Automated MAD and MIR structure solution.

Authors:  T C Terwilliger; J Berendzen
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1999-04

7.  Protein-protein interactions between hepatitis C virus nonstructural proteins.

Authors:  Maria Dimitrova; Isabelle Imbert; Marie Paule Kieny; Catherine Schuster
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

8.  Mutations in hepatitis C virus RNAs conferring cell culture adaptation.

Authors:  V Lohmann; F Körner; A Dobierzewska; R Bartenschlager
Journal:  J Virol       Date:  2001-02       Impact factor: 5.103

9.  Oligomerization and cooperative RNA synthesis activity of hepatitis C virus RNA-dependent RNA polymerase.

Authors:  Q May Wang; Michelle A Hockman; Kirk Staschke; Robert B Johnson; Katharine A Case; Jirong Lu; Steve Parsons; Faming Zhang; Radhakrishnan Rathnachalam; Karla Kirkegaard; Joseph M Colacino
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

10.  Purification and characterization of hepatitis C virus non-structural protein 5A expressed in Escherichia coli.

Authors:  Luyun Huang; Elena V Sineva; Michele R S Hargittai; Suresh D Sharma; Mehul Suthar; Kevin D Raney; Craig E Cameron
Journal:  Protein Expr Purif       Date:  2004-09       Impact factor: 1.650

View more
  199 in total

1.  Amphipathic alpha-helix AH2 is a major determinant for the oligomerization of hepatitis C virus nonstructural protein 4B.

Authors:  Jérôme Gouttenoire; Philippe Roingeard; François Penin; Darius Moradpour
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

Review 2.  Hepatitis C virus: assembly and release of virus particles.

Authors:  Daniel M Jones; John McLauchlan
Journal:  J Biol Chem       Date:  2010-05-10       Impact factor: 5.157

3.  Measuring antiviral activity of benzimidazole molecules that alter IRES RNA structure with an infectious hepatitis C virus chimera expressing Renilla luciferase.

Authors:  Shuanghu Liu; Cassie A Nelson; Li Xiao; Ling Lu; Punit P Seth; Darrell R Davis; Curt H Hagedorn
Journal:  Antiviral Res       Date:  2010-11-12       Impact factor: 5.970

Review 4.  Viral determinants of resistance to treatment in patients with hepatitis C.

Authors:  Anette Wohnsland; Wolf Peter Hofmann; Christoph Sarrazin
Journal:  Clin Microbiol Rev       Date:  2007-01       Impact factor: 26.132

Review 5.  Viral proteomics.

Authors:  Karen L Maxwell; Lori Frappier
Journal:  Microbiol Mol Biol Rev       Date:  2007-06       Impact factor: 11.056

Review 6.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

Review 7.  Architecture and biogenesis of plus-strand RNA virus replication factories.

Authors:  David Paul; Ralf Bartenschlager
Journal:  World J Virol       Date:  2013-05-12

8.  Roles of the two distinct proteasome pathways in hepatitis C virus infection.

Authors:  Ikuo Shoji
Journal:  World J Virol       Date:  2012-04-12

Review 9.  Hepatitis C virus: Is it time to say goodbye yet? Perspectives and challenges for the next decade.

Authors:  Heidi Barth
Journal:  World J Hepatol       Date:  2015-04-18

10.  A virocidal amphipathic {alpha}-helical peptide that inhibits hepatitis C virus infection in vitro.

Authors:  Guofeng Cheng; Ana Montero; Pablo Gastaminza; Christina Whitten-Bauer; Stefan F Wieland; Masanori Isogawa; Brenda Fredericksen; Suganya Selvarajah; Philippe A Gallay; M Reza Ghadiri; Francis V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.